Portage biotech reports fiscal year-ended march 31, 2023 financial results and business update

Westport, conn., july 31, 2023 (globe newswire) -- portage biotech inc. (nasdaq: prtg), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in combination, today announced financial results for the fiscal year ended march 31, 2023.
ATON Ratings Summary
ATON Quant Ranking